Description
Kimyrsa is an intravenous antibiotic containing oritavancin diphosphate, a lipoglycopeptide used to treat certain bacterial infections like skin and soft tissue infections. It comes as a lyophilized powder that is mixed into a solution for injection. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Oritavancin diphosphate — ANDA 214155 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214155 |
Tags
- drug-information
- drug-manufacturers
- prescription-drugs
- drug
- medications